Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Biotech IPOs continue attracting cash 

IPOs by Recursion, Biomea and Akoya continue the trend of strong debuts by biotech companies on NASDAQ

April 17, 2021 1:45 AM UTC

A trio of IPOs on Friday continued the trend of strong debuts by biotech companies on NASDAQ. The offerings from Recursion, Biomea and Akoya all priced at the top of their range and traded up in the aftermarket. 

Investors will be tracking how well the stocks perform in the near term as IPO performance is one of the key metrics investors are tracking this quarter to gauge whether 1Q21’s record financing activity is going to start to slow...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article